Growth Equity Investors

As the growth equity asset class becomes more "crowded", competition for deal flow intensifies, and the need for sponsors to distinguish themselves among an increasingly sophisticated community of entrepreneurs becomes more urgent.

Growth equity is one of the fastest growing investment strategies, involving rapidly growing, revenue stage businesses with proven business models and accelerating profitability. Superior returns are generated by visionary management teams executing disciplined growth strategies supported by finely-tuned capital structures. Liquidity and exits can be achieved through equity and debt re-capitalizations, IPO, or strategic sale.

Healthios has advised on more than 30 growth equity transactions, representing aggregate value in excess of $2.5 billion. Our focus on healthcare, extensive industry relationships and strong command of the strategic environment positions us to make extraordinary contributions to growth equity investors and their portfolio companies.